214 related articles for article (PubMed ID: 31717736)
1. Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
Naumann P; Eberlein J; Farnia B; Liermann J; Hackert T; Debus J; Combs SE
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717736
[TBL] [Abstract][Full Text] [Related]
2. Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
Naumann P; Eberlein J; Farnia B; Hackert T; Debus J; Combs SE
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31126040
[No Abstract] [Full Text] [Related]
3. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
[TBL] [Abstract][Full Text] [Related]
4. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
6. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study.
Dalal S; Hui D; Bidaut L; Lem K; Del Fabbro E; Crane C; Reyes-Gibby CC; Bedi D; Bruera E
J Pain Symptom Manage; 2012 Aug; 44(2):181-91. PubMed ID: 22695045
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia.
Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2024 May; ():. PubMed ID: 38725139
[TBL] [Abstract][Full Text] [Related]
8. Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.
Sandini M; Patino M; Ferrone CR; Alvarez-Pérez CA; Honselmann KC; Paiella S; Catania M; Riva L; Tedesco G; Casolino R; Auriemma A; Salandini MC; Carrara G; Cristel G; Damascelli A; Ippolito D; D'Onofrio M; Lillemoe KD; Bassi C; Braga M; Gianotti L; Sahani D; Fernández-Del Castillo C
JAMA Surg; 2018 Sep; 153(9):809-815. PubMed ID: 29801062
[TBL] [Abstract][Full Text] [Related]
9. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients.
Rutten IJ; van Dijk DP; Kruitwagen RF; Beets-Tan RG; Olde Damink SW; van Gorp T
J Cachexia Sarcopenia Muscle; 2016 Sep; 7(4):458-66. PubMed ID: 27030813
[TBL] [Abstract][Full Text] [Related]
10. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
Anker SD; Coats AJ
Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.
Nattenmüller J; Wochner R; Muley T; Steins M; Hummler S; Teucher B; Wiskemann J; Kauczor HU; Wielpütz MO; Heussel CP
PLoS One; 2017; 12(1):e0169136. PubMed ID: 28107410
[TBL] [Abstract][Full Text] [Related]
13. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
[TBL] [Abstract][Full Text] [Related]
14. Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status.
Chovsepian A; Prokopchuk O; Petrova G; Gjini T; Kuzi H; Heisz S; Janssen KP; Martignoni ME; Friess H; Hauner H; Rohm M
Mol Metab; 2023 Jul; 73():101729. PubMed ID: 37094629
[TBL] [Abstract][Full Text] [Related]
15. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival.
Kiss N; Beraldo J; Everitt S
Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673
[TBL] [Abstract][Full Text] [Related]
16. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
17. Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer.
Bye A; Wesseltoft-Rao N; Iversen PO; Skjegstad G; Holven KB; Ulven S; Hjermstad MJ
Med Oncol; 2016 Jun; 33(6):54. PubMed ID: 27119533
[TBL] [Abstract][Full Text] [Related]
18. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
20. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
